William Blair downgraded Medpace (MEDP) to Market Perform from Outperform.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MEDP:
- Medpace Holdings: Strong Q1 Performance and Strategic Moves Justify Buy Rating
- Closing Bell Movers: Calix jumps 15% on earnings beat, guidance raise
- Medpace reports Q1 EPS $3.67, consensus $3.08
- Medpace raises FY25 EPS view to $12.26-$13.04 from $11.93-$12.69
- Options Volatility and Implied Earnings Moves Today, April 21, 2025